Results 11 to 20 of about 140 (59)

[Expert consensus on the management of B-cell lymphoma-related cardiovascular diseases with Bruton tyrosine kinase inhibitors (2023)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2023
Hematological Oncology Committee of China Anti-Cancer Association   +3 more
europepmc   +1 more source

[Expert Consensus on Rational Use and Monitoring of Small Molecule Targeted Drugs for Lung Cancer]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi
Zhao L   +3 more
europepmc   +1 more source

[Chinese expert consensus on prevention and treatment of immunotherapeutic and molecular targeted agents-related infections in patients with hematological malignancies (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Infectiology Group   +6 more
europepmc   +1 more source

Guidance on the management of adverse reactions induced by poly(ADP-ribose) polymerase inhibitors. [PDF]

open access: yesZhejiang Da Xue Xue Bao Yi Xue Ban, 2022
Society of Obstetrics and Gynecology of Zhejiang Medical Association   +4 more
europepmc   +1 more source

[The guidelines for diagnosis and treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma in China (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Hematological Oncology Committee of China Anti-Cancer Association   +2 more
europepmc   +1 more source

[Clinical analysis of 16 cases of adult acute B-lymphoblastic leukemia treated with blinatumomab]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Liu ZY   +4 more
europepmc   +1 more source

[Clinical Practice Guidelines for the Management of Brain Metastases from 
Non-small Cell Lung Cancer with Actionable Gene Alterations in China (2025 Edition)]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi
Lung Cancer Medical Education Committee of Chinese Medical Education Association   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy